NFKB1 and breast cancer: With Calebin A administration, remarkable down-regulation of the BC-induced osteoclastogenesis could be determined, whereas RANKL-associated and IκBα-mediated NF-κB signaling was clearly modulated (19), underlining Calebin A’s wide-ranging usability.